Matthew J. Reilly, P.C.

UnitedHealth Group (UHG) in antitrust litigation challenging United’s $13 billion acquisition of Change Healthcare; verdict secured for the client following a 12-day bench trial when the court denied the federal government's request to enjoin the merger. The litigation win was on front page of the WSJ and was awarded Litigator of the Week for this victory

UHG in its acquisitions of LHC Group and a large multi-specialty provider group; Full compliance with a Second Request (one from FTC and one from DOJ) and both deals closed without a consent

CDK in a high-stakes antitrust conduct matter. Brought in to litigate the matter seven years after the plaintiffs filed the complaint

SEG. Southeastern Grocers, parent company of Winn-Dixie, Harveys Supermarket, and Fresco y Más grocery stores, in a comprehensive strategic divestiture of its business to ALDI, Fresco Retail Group, and two large pharmacy chains

Resonetics in its $900 million acquisition of SAES’s medical nitinol business; FTC closed the investigation after full compliance with a Second Request

Celanese Corp. in its $11 billion acquisition of a majority of DuPont’s Mobility & Materials business. The FTC closed its investigation after full compliance with a Second Request

Prince-Ferro. Prince International, an American Securities portfolio company that produces specialty chemicals, minerals, and industrial additives, in its $2.1 billion acquisition of Ferro, and its related divestiture to KPS Capital Partners

Hellman & Friedman, as part of an investor group, in the $10.2 billion acquisition of Zendesk

Owl Rock Capital Group in its business combination with Dyal Capital Partners to form Blue Owl Capital Inc., and Blue Owl’s subsequent $12.15 billion business combination with Altimar Acquisition Corp.

Olympus Partners-backed Liqui-Box in its acquisition of DS Smith’s plastics division. The DOJ closed its investigation after full compliance with the Second Request and resulting divestiture to TriMas Corp.

Bristol Myers Squibb in its $13.1 billion acquisition of MyoKardia

Staples Inc. in its $996 million acquisition of Essendant Inc. The FTC cleared the transaction, subject to a 3-2 vote on a firewall consent, following full compliance with a Second Request

AbbVie in its $63 billion acquisition of Allergan, obtaining approval of the divestiture by a 3-2 vote of the FTC, allowing the deal to close less than eleven months after signing

Tenet Healthcare Corporation in antitrust litigation arising out of its proposed sale of two hospitals in Memphis, Tennessee. KE was brought in months after the Second Request issued

Bristol-Myers Squibb in its $90 billion acquisition of Celgene and its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen

GlaxoSmithKline in its $12.7 billion joint venture with Pfizer to combine their consumer health businesses

Spectrum Brands in its $2 billion carve-out sale of its global consumer battery business to Energizer

Mazor Robotics in its $1.6 billion sale to Medtronic plc

Strayer Education in its $1.9 billion merger of equals with Capella Education Company, creating a national leader in education innovation

Tronox Limited in its $2.2 billion acquisition of Cristal’s TiO(2) business. The deal closed after litigation on the merits with the FTC and the divestiture of Cristal’s North American titanium dioxide assets

Tronox Limited in antitrust litigation arising from the FTC’s challenge to Tronox’s $2.2 billion worldwide acquisition of Cristal, Ltd.’s titanium dioxide business. The parties entered into a settlement, in which the FTC allowed the acquisition to proceed with the divestiture, a remedy that addressed the antitrust concerns